According to its own information, the US pharmaceutical company Moderna could develop a targeted booster vaccination for Omikron from March and have it ready for an application for approval in the USA.
SN/www.imago-images.de/christian ohde
Moderna President Stephen Hoge told Reuters on Wednesday that the whole process could take three to four months. “Realistically, the Omikron-specific boosters won’t come before March and maybe more in the second quarter.”
Accessed on December 2nd, 2021 at 8:45 am on https://www.sn.at/panorama/wissen/omikron-vari-moderna-steller-booster-ab-maerz-in-aussicht-113394478
